ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 649826 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 649826; 2) Community: the network communities that were significantly associated with the response to NSC 649826; 3) Molecule: the relationships between components within communities and NSC 649826; 4) MDR: the compounds that were significantly associated with the NSC 649826.

NSC Compound Enrichment Correlation
NSC 620687 Null 0.00486817664672774 0.4192601
NSC 635544 Null 0.00486817664672774 0.51524518
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.00486817664672774 0.35345504
NSC 627991 Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- 0.00503396694999378 0.51048021
NSC 682817 7,10:11,14-Dietheno-28H-23,27-nitrilo-22H-dibenzo[b,p] [1,18,5,14]dioxadiazacyclopentacosine 0.0050339669499938 -0.21811524
NSC 107124 Camptothecin Derivative 0.00550789647802199 0.14065167
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.00550789647802199 0.49144745
NSC 628121 Null 0.00550789647802199 0.35008792
NSC 629749 .beta.-Lapachone 0.00550789647802199 0.43561385
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.00550789647802199 0.52049065
Total:79  Current:16    [First] [Prev] [Next] [Last]